Replies to post #235502 on Amarin Corp Plc (AMRN)

[HDGabor]

K-

No way BP prices 50% more for Rest of the world where Amarin has to sell the rights to others and only collect a small percentage in residual.

My view: BP will price the BP GIA higher than Amarin GIA. Maybe the 50% is high … some DD required (e.g. what is the licensing revenue of other Co that has a GIA in the US only) but I do not think it worth the effort.

Europe accounted for less than 15% of overall sales for best selling statin without having to be a residual, no way Amarin gets more than 10-15% from a BP for ROW

Lipitor revenue (2007):
- US: 7.2 bn
- RoW: 5.5 bn (76% of US, 43% of total)
- Total: 12.7 bn

Best,
G